Sign Up Today and Learn More About Cartiva Stock

Invest in or calculate the value of your shares in Cartiva or other pre-IPO companies through EquityZen's platform.

Get Started

Cartiva Stock

Cartiva is a developer of innovative products for the treatment of cartilage injuries and osteoarthritis.

About Cartiva Stock

Founded

2011

Headquarters

Alpharetta, GA, US

Total Funding

24.3M

Cartiva, Inc., located in Alpharetta, Georgia, is a private, venture capital-backed company that was spun out from Carticept Medical, Inc. in December 2011. Cartiva is dedicated to improving the quality of life for patients with osteoarthritis or cartilage damage through the development of novel therapies. An estimated 27 million Americans suffer from osteoarthritis, a chronic degenerative joint disease characterized by the breakdown of the cartilage in the joint. An additional two million Americans injure the cartilage in their knees each year. Many people do not respond well to current medical treatments or are not eligible for major surgery such as a total joint replacement. Cartiva’s mission is to develop and market products to help physicians treat osteoarthritis and cartilage injuries and the related pain more effectively. Our management team, board of directors and medical advisors are comprised of industry-recognized professionals who possess broad knowledge in orthopedics and extensive experience managing innovative medical devices from development through clinical trials, FDA approval and successful commercialization.

Cartiva Management

Leadership team at Cartiva

Director, Clinical Affairs

Katie E. Strother

VP, Regulatory, Quality & Clinical Affairs

Deborah J. Moore

Locked Features

Join now and verify your accreditation status to gain access to:

  • Cartiva current valuation
  • Cartiva stock price
  • Available deals in Cartiva and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Cartiva stock?

Accredited investors can buy pre-IPO stock in companies like Cartiva through EquityZen funds. These investments are made available by existing Cartiva shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Cartiva stock?

Shareholders can sell their Cartiva stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."